Abstract:BackgroundIn haemato-oncologic patients bacteremia is frequent increasing mortality rates, therefore surveillance and close follow up is essential to optimize treatment. The use of invasive devices used frequently in this population increases the incidence of infections by gram-positive microorganisms (currently gram-negative bacilli have been added). Therefore, we propose the characterization the microorganisms to identify the epidemiologic conditions, and the areas of improvement to establish improvement care strategies for this population.MethodsWe conducted a retrospective study at the haemato-oncologic diseases service at the National Medical Center "20 de Noviembre". Prevalence of bacteremia in pediatric patients with cancer and neutropenia in Mexican population, which ranges from 8% to 36%, assuming that our results could be similar to higher percentage, employing a proportion formula with a study population of 65 patients.ResultsIt was demonstrated in our population studied that in all cases of bacteremia, patients were in depth neutropenia at diagnosis. The most prevalence phase of chemotherapy was Induction phase (69.2%), with Total XV ST Jude protocol. The clinical data revealed the following frequencies in 100% of the patients: Fever (92%), Tachycardia (72%), Shivering and piloerection (65%), Elevated acute-phase reactants PCT (51%), CPR (32%), and Tachypnea (28%). Cases of Central Line-associated Bloodstream Infection (CLABSI) was reported in 86.2%, affecting individuals with vascular devices. The predominant microbiological isolate in our patients was Escherichia coli ESBL (31%), followed by Klebsiella pneumoniae (18%), and Pseudomonas aeruginosa (13.8%), Staphylococcus epidermidis (11%). Other bacteria were identified at even lower frequencies, such as Stenotrophomonas maltophilia (5%), Klebsiella oxytoca (5%), Staphylococcus aureus (3%), Serratia marcescens (3%), Enterococcus faecalis (3%), and Enterobacter cloacae (3%). The least observed in our population was the identification of Acinetobacter bauman nii (2%). The different outcomes recorded in our sample were highly consistent, with a resolution rate of infection in 97% of cases and 3% of cases resulting in death attributable to bacteremia (Table 1).ConclusionThe low mortality found in this study may be due to the early initiation of empirical antibiotic treatment in "golden hour", a protocol carried out in our Center, as well as the identification of severity scales.Table 1 General characteristics of children with bacteremia and malignant neoplasiaTotaln = 65 Neoplasm TypepHematologicaln = 48 Solidn = 17 Age, years8.13 ± 3.77.83 ± 3.79.00 ± 3.770.276Gender Female Male41 (63%)24 (37%)34 (71%)14 (29%)7 (41%)10 (69%)0.059Invasive Devices Without invasive devices Vascular catheter Urinary catheter Endotrachealtube Others2 (3%)63 (97%)9 (14%)8 (12%)1 (2%)2 (4%)46 (96%)8 (17%)5 (10%)1 (2%)017 (100%)2 (12%)2 (12%)00.96990.96990.928111 Depth Neutropenia Days65 (100%)9 (6 – 12)48 (100%)10 (6.5 - 11.5)17 (100%)7 (5.2 – 13.5)NA: 0.4931 * Microbiológical isolation Escherichia coli Klebsiella pneumoniae Pseudomonas aeruginosa S. Epidermidis S. Maltophilia Klebsiella oxytoca Staphyloccocus Aureus Serratia marcescens Enterococcus faecalis Enterobacter cloacae Staphyloccocus hominis Acinetobacter baumannii 21 (32%)12 (18%)9 (13.8%)7 (11%)3 (5%)3 (5%)2 (3%)2 (3%)2 (3%)2 (3%)1 (2%)1 (2%)18 (38%)10(21%)8 (17%)5 (10%)2 (4%)1 (2%)1 (2%)2 (4%)2 (4%)2 (4%)1 (2%)1 (2%)3 (18%)2 (12%)1 (6%)2 (12%)1 (6%)2 (12%)1 (2%)00000NAHospital stay (days)25(17.5 – 29.5)26(17.5 – 29.5)24(17.2 – 29.5)0.9107 * Outcome Infection resolved Attributable death63 (97%)2 (3%)46 (96%)2 (4%)17 (100%)00.9699

National study reveals gram negative bacteremia on contemporary pediatric AML protocol

Bacteremia in Children with Solid Tumors: Etiology, Antimicrobial Susceptibility, Factors Associated with Multidrug Resistance, and Mortality

Empirical polymyxin B therapy in febrile neutropenic patients with hematological diseases: A prospective, multicenter, observational clinical study

Non-fermentative Gram-negative rods bacteremia in children with cancer: a 14-year single-center experience

Clinical Characteristics, Management, and Outcomes of Bacteremia in Children with Cancer: A Retrospective Study

Bacteremias in Hemato-Oncological Pediatric Patients: Clinical and Microbiological Characteristics

Th1/Th2 cytokine profiles in G+/G- bacteremia in pediatric hematology/oncology patients.

Assessing the Theoretical Efficacy of Combination Therapy Against Gram-Negative Infections in Neutropenic Pediatric Cancer Patients: Insights from the Statistical Analysis of Survey Data

Analysis of bacteremia at first-line antibiotic treatment for febrile neutropenia in children and adolescents: A retrospective, single-center analysis

Clinical Features of Bloodstream Infection in Children with Haematological Malignancies

Clinical Characteristics and Risk Factors for Bloodstream Infections in Children with Cancer: A Report from a Pediatric Hematology Oncology Unit

Third generation cephalosporin resistant Enterobacteriaceae and multidrug resistant gram-negative bacteria causing bacteremia in febrile neutropenia adult cancer patients in Lebanon, broad spectrum antibiotics use as a major risk factor, and correlation with poor prognosis

Etiology of Septicemia in Children with Acute Leukemia

Etiological analysis of nosocomial infections in patients with acute leukemia and clinical treatment

High frequency of viridians group streptococci bacteremia in pediatric neuroblastoma high-risk patients during induction chemotherapy

A 14-Year Cohort of Candidemia in the Pediatric Population in a Tertiary Center in Jerusalem: Clinical Characteristics, Antifungal Susceptibility, and Risk Factors for Mortality

Pseudomonas Bacteremia in Children: Clinical and Microbiologic Features and Risk Factors of Mortality: A Retrospective Cohort Study

Characterization of gram-negative bloodstream infections in hospitalised Australian children and their clinical outcomes

Antibiotic Resistant Bloodstream Infections in Pediatric Patients Receiving Chemotherapy or Hematopoietic Stem Cell Transplant: Factors Associated with Development of Resistance, Intensive Care Admission and Mortality

Investigation of infections status in pediatric patients with acute myeloid leukemia during the induction period-a retrospective study in two medical centers

Gram-negative bacteremia, the risk factors, and outcome in children